Publicação: Is 44-hour better than 24-hour ambulatory blood pressure monitoring in hemodialysis?
dc.contributor.author | Martin, Luis Cuadrado [UNESP] | |
dc.contributor.author | Franco, Roberto Jorge da Silva [UNESP] | |
dc.contributor.author | Gavras, I. | |
dc.contributor.author | Matsubara, Beatriz Bojikian [UNESP] | |
dc.contributor.author | Okoshi, Katashi [UNESP] | |
dc.contributor.author | Zanati, S. G. [UNESP] | |
dc.contributor.author | Caramori, J. T. [UNESP] | |
dc.contributor.author | Barretti, Pasqual [UNESP] | |
dc.contributor.author | Balbi, André Luis [UNESP] | |
dc.contributor.author | Gavras, H. | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.contributor.institution | School of Medicine | |
dc.date.accessioned | 2014-05-27T11:22:03Z | |
dc.date.available | 2014-05-27T11:22:03Z | |
dc.date.issued | 2006-12-01 | |
dc.description.abstract | The aim of this study is to evaluate if hemodialysis (HD) patients with similar blood pressure (BP) in the whole inter-HD period could have different target organ lesions and survival if the behavior of BP differs from the first to the second day of the inter-HD period. The present study compares 44-hour ambulatory BP monitoring (ABPM) patterns in 45 HD patients. Three BP patterns emerged: group A (n = 15) had similar BPs throughout (138 ± 11/88 ± 12 in the first 22 h vs. 140 ± 11/87 ± 12 mm Hg in the second 22-hour period); group B (n = 15) had a significant systolic BP rise from the first to the second period (132 ± 15/80 ± 12 vs. 147 ± 12/86 ± 13 mm Hg, p < 0.05); group C (n = 15) had significantly higher BPs (p < 0.05) than the other 2 groups throughout the whole inter-HD period, with no significant change between the 2 halves (172 ± 14/108 ± 12 vs. 173 ± 18/109 ± 14 mm Hg). Ventricular mass and survival during the 30-month follow-up period were statistically significantly better in group A, intermediate in group B and worse in group C. The data suggest that a 44-hour ABPM is more accurate than a 24-hour one in evaluating organ lesion and prognosis in HD patients. Copyright © 2006 S. Karger AG. | en |
dc.description.affiliation | Division of Nephrology Botucatu Medical School, Botucatu | |
dc.description.affiliation | Division of Cardiology Department of Internal Medicine Botucatu Medical School, Botucatu | |
dc.description.affiliation | Hypertension and Atherosclerosis Section Boston University School of Medicine, Boston, MA | |
dc.description.affiliation | Department of Internal Medicine Botucatu Medical School, PO Box 584, Rubiao Junior, Botucatu 18618-000, SP | |
dc.description.affiliationUnesp | Division of Nephrology Botucatu Medical School, Botucatu | |
dc.description.affiliationUnesp | Division of Cardiology Department of Internal Medicine Botucatu Medical School, Botucatu | |
dc.description.affiliationUnesp | Department of Internal Medicine Botucatu Medical School, PO Box 584, Rubiao Junior, Botucatu 18618-000, SP | |
dc.format.extent | 273-279 | |
dc.identifier | http://dx.doi.org/10.1159/000096176 | |
dc.identifier.citation | Kidney and Blood Pressure Research, v. 29, n. 5, p. 273-279, 2006. | |
dc.identifier.doi | 10.1159/000096176 | |
dc.identifier.issn | 1420-4096 | |
dc.identifier.lattes | 7095933557855151 | |
dc.identifier.lattes | 6990977122340795 | |
dc.identifier.lattes | 1590971576309420 | |
dc.identifier.lattes | 5496411983893479 | |
dc.identifier.lattes | 5697804493071661 | |
dc.identifier.lattes | 4923203168446615 | |
dc.identifier.orcid | 0000-0003-4979-4836 | |
dc.identifier.scopus | 2-s2.0-33845923869 | |
dc.identifier.uri | http://hdl.handle.net/11449/69272 | |
dc.language.iso | eng | |
dc.relation.ispartof | Kidney and Blood Pressure Research | |
dc.relation.ispartofjcr | 3.000 | |
dc.relation.ispartofsjr | 0,540 | |
dc.rights.accessRights | Acesso restrito | |
dc.source | Scopus | |
dc.subject | Ambulatory blood pressure monitoring | |
dc.subject | Hemodialysis | |
dc.subject | Left ventricular hypertrophy | |
dc.subject | antihypertensive agent | |
dc.subject | calcitriol | |
dc.subject | erythropoietin | |
dc.subject | adult | |
dc.subject | anuria | |
dc.subject | blood pressure monitoring | |
dc.subject | clinical article | |
dc.subject | controlled study | |
dc.subject | female | |
dc.subject | follow up | |
dc.subject | heart left ventricle | |
dc.subject | heart left ventricle hypertrophy | |
dc.subject | heart ventricle | |
dc.subject | heart ventricle volume | |
dc.subject | hemodialysis | |
dc.subject | human | |
dc.subject | hypertension | |
dc.subject | male | |
dc.subject | priority journal | |
dc.subject | prognosis | |
dc.subject | statistical significance | |
dc.subject | survival rate | |
dc.subject | systolic blood pressure | |
dc.subject | treatment duration | |
dc.subject | Adult | |
dc.subject | Aged | |
dc.subject | Algorithms | |
dc.subject | Antihypertensive Agents | |
dc.subject | Blood Pressure Monitoring, Ambulatory | |
dc.subject | Echo-Planar Imaging | |
dc.subject | Electrocardiography | |
dc.subject | Female | |
dc.subject | Heart Rate | |
dc.subject | Humans | |
dc.subject | Hypertension | |
dc.subject | Kidney Failure, Chronic | |
dc.subject | Kidney Function Tests | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Renal Dialysis | |
dc.subject | Survival Analysis | |
dc.title | Is 44-hour better than 24-hour ambulatory blood pressure monitoring in hemodialysis? | en |
dc.type | Artigo | |
dcterms.license | http://www.karger.com/Services/RightsPermissions | |
dspace.entity.type | Publication | |
unesp.author.lattes | 5496411983893479[8] | |
unesp.author.lattes | 7095933557855151 | |
unesp.author.lattes | 6990977122340795 | |
unesp.author.lattes | 1590971576309420 | |
unesp.author.lattes | 5697804493071661[9] | |
unesp.author.lattes | 4923203168446615 | |
unesp.author.orcid | 0000-0002-0607-8189[6] | |
unesp.author.orcid | 0000-0003-4979-4836[8] | |
unesp.author.orcid | 0000-0001-8366-5064[9] | |
unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu | pt |
unesp.department | Clínica Médica - FMB | pt |